Ataxia telangiectasia mutated pathway disruption affects hepatic DNA and tissue damage in nonalcoholic fatty liver disease

Medicine & Life Sciences

• Ataxia Telangiectasia 87%
• Non-alcoholic Fatty Liver Disease 74%
• DNA Damage 60%
• Fatty Liver 49%
• Liver 35%
• Mitochondrial DNA 24%
• Growth 19%
• Connexin 43 9%
• Phosphoproteins 9%
• Inflammation 9%
• Messenger RNA 8%
• Disease Susceptibility 8%
• Genomics 7%
• Cell Cycle Checkpoints 7%
• Albumins 6%
• Fatty Acids 6%
• Genes 6%
• Disease Progression 6%
• Phosphotransferases 5%
• Carcinogenesis 5%
• Homeostasis 5%
• Healthy Volunteers 5%
• Cell Proliferation 5%
• Clinical Trials 4%
• Health 3%
• Wounds and Injuries 3%
• Population 2%
• Proteins 2%
• Therapeutics 1%

Chemical Compounds

• Cell Growth Inhibition 100%
• Marker 60%
• Pharmacological Metabolism 53%
• Protein 28%